MERZOUKI ABDERRAZZAK 4
4 · Sunshine Biopharma, Inc · Filed Oct 7, 2019
Insider Transaction Report
Form 4
MERZOUKI ABDERRAZZAK
DirectorChief Operating Officer
Transactions
- Award
Common Stock
2019-09-02$0.00/sh+13,000,000$13,000→ 18,850,000 total
Footnotes (1)
- [F1]Issuer effectuated a reverse stock split effective February 1, 2019 wherein one share of Common Stock of the Issuer was issued for each 20 shares of Common Stock issued and oustanding resulting in Reporting Person owning 5,850,000 shares of Common Stock of the Issuer as of that date.